CDS-话题@MedSci

#CDS#

98篇内容 | 1727人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1377591, encodeId=7bc313e7591aa, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：协同创新促进发展规范普及共赢未来, objectType=article, longId=60559, objectId=55a56055994, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55a56055994, replyNumber=0, likeNumber=36, createdTime=2015-12-15, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55a56055994, moduleTitle=CDS 2015：协同创新促进发展规范普及共赢未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55a56055994)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377590, encodeId=1d1f13e7590ce, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015 MedSci专访陈莉明教授：《中国血糖监测临床应用指南 2015》新版发布！, objectType=article, longId=60558, objectId=620f6055844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=620f6055844, replyNumber=0, likeNumber=34, createdTime=2015-12-15, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=620f6055844, moduleTitle=CDS 2015 MedSci专访陈莉明教授：《中国血糖监测临床应用指南 2015》新版发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=620f6055844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377589, encodeId=bdcb13e758903, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, objectType=article, longId=60556, objectId=f8216055671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8216055671, replyNumber=0, likeNumber=18, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8216055671, moduleTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8216055671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377588, encodeId=1b6013e758825, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）, objectType=article, longId=60555, objectId=fdbf6055558, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdbf6055558, replyNumber=0, likeNumber=36, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdbf6055558, moduleTitle=CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdbf6055558)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377587, encodeId=7aeb13e758723, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS2015：两项真实世界的糖尿病研究结果发布, objectType=article, longId=60554, objectId=46f760554ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46f760554ba, replyNumber=0, likeNumber=38, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46f760554ba, moduleTitle=CDS2015：两项真实世界的糖尿病研究结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46f760554ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377586, encodeId=285f13e7586ee, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）, objectType=article, longId=60553, objectId=902360553c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=902360553c9, replyNumber=0, likeNumber=52, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=902360553c9, moduleTitle=CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=902360553c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377585, encodeId=a0b313e7585f3, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：滕卫平：1型糖尿病表观遗传学研究进展, objectType=article, longId=60541, objectId=7d2460541b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d2460541b4, replyNumber=0, likeNumber=33, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d2460541b4, moduleTitle=CDS 2015：滕卫平：1型糖尿病表观遗传学研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d2460541b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377584, encodeId=f95c13e758455, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：ORBIT研究启示, objectType=article, longId=60540, objectId=5f2d6054056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f2d6054056, replyNumber=0, likeNumber=43, createdTime=2015-12-14, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f2d6054056, moduleTitle=CDS 2015：ORBIT研究启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f2d6054056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377583, encodeId=ba7013e75831c, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2015：翁建平谈中国近20年糖尿病领域研究带给我们的启示, objectType=article, longId=60473, objectId=f3bc604e32a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3bc604e32a, replyNumber=0, likeNumber=48, createdTime=2015-12-11, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3bc604e32a, moduleTitle=CDS 2015：翁建平谈中国近20年糖尿病领域研究带给我们的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3bc604e32a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377582, encodeId=738a13e758205, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=MedSci参加中华医学会糖尿病学分会第十九次全国学术会议（CDS 2015）, objectType=article, longId=60469, objectId=8cdb604697b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cdb604697b, replyNumber=0, likeNumber=41, createdTime=2015-12-11, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cdb604697b, moduleTitle=MedSci参加中华医学会糖尿病学分会第十九次全国学术会议（CDS 2015）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cdb604697b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377581, encodeId=b45913e7581aa, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=Lancet Oncol：连续深度镇静（CDS）可成为癌症晚期患者姑息治疗的选择, objectType=article, longId=59243, objectId=bc6d592433f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6d592433f, replyNumber=0, likeNumber=48, createdTime=2015-11-23, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6d592433f, moduleTitle=Lancet Oncol：连续深度镇静（CDS）可成为癌症晚期患者姑息治疗的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6d592433f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377580, encodeId=f50413e758096, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDSR：对孕妇进行生殖道感染的筛查和治疗是有必要的, objectType=article, longId=50861, objectId=b7da50861f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7da50861f8, replyNumber=0, likeNumber=34, createdTime=2015-05-18, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7da50861f8, moduleTitle=CDSR：对孕妇进行生殖道感染的筛查和治疗是有必要的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7da50861f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377579, encodeId=bcaf13e75795c, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDSR：孕期补充锌减少早产率, objectType=article, longId=50854, objectId=f18e5085418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f18e5085418, replyNumber=0, likeNumber=46, createdTime=2015-05-18, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f18e5085418, moduleTitle=CDSR：孕期补充锌减少早产率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f18e5085418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377578, encodeId=f6e913e7578bf, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2014：基层——糖尿病防控**线, objectType=article, longId=42437, objectId=090b4243ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=090b4243ea8, replyNumber=0, likeNumber=28, createdTime=2014-11-13, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=090b4243ea8, moduleTitle=CDS 2014：基层——糖尿病防控**线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=090b4243ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377577, encodeId=c49c13e7577c9, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=项坤三院士获首届CDS科学贡献奖, objectType=article, longId=42376, objectId=f0d0423e670, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d0423e670, replyNumber=0, likeNumber=30, createdTime=2014-11-12, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d0423e670, moduleTitle=项坤三院士获首届CDS科学贡献奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0d0423e670)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377576, encodeId=be9813e757656, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2014：东西方胰岛素抵抗是否存在差异?, objectType=article, longId=42373, objectId=7f16423e37d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f16423e37d, replyNumber=0, likeNumber=30, createdTime=2014-11-12, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f16423e37d, moduleTitle=CDS 2014：东西方胰岛素抵抗是否存在差异?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f16423e37d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377575, encodeId=448813e757553, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDSR：维生素C防治感冒—争论还在继续, objectType=article, longId=32296, objectId=61073229696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61073229696, replyNumber=0, likeNumber=42, createdTime=2014-03-26, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61073229696, moduleTitle=CDSR：维生素C防治感冒—争论还在继续, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61073229696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377574, encodeId=717513e757430, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS发布《基于胰高血糖素样肽-1降糖药物的临床应用共识》, objectType=article, longId=31923, objectId=ad9b319232c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9b319232c, replyNumber=0, likeNumber=34, createdTime=2014-03-16, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9b319232c, moduleTitle=CDS发布《基于胰高血糖素样肽-1降糖药物的临床应用共识》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9b319232c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377573, encodeId=f07413e75735c, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDSR：β-内酰胺类加氨基糖苷类抗生素有害, objectType=article, longId=31417, objectId=73e23141e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73e23141e0c, replyNumber=0, likeNumber=39, createdTime=2014-03-05, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73e23141e0c, moduleTitle=CDSR：β-内酰胺类加氨基糖苷类抗生素有害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73e23141e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1377572, encodeId=352313e75724e, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, objectTitle=CDS 2013：中国糖尿病研究获奖名单, objectType=article, longId=27683, objectId=b86b2e6837a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b86b2e6837a, replyNumber=0, likeNumber=44, createdTime=2013-12-08, rootId=0, userName=yangpeizhi, userId=ec25412, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b86b2e6837a, moduleTitle=CDS 2013：中国糖尿病研究获奖名单, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b86b2e6837a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CDS

2020-05-29

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：协同创新促进发展规范普及共赢未来

2015-12-15

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015 MedSci专访陈莉明教授：《中国血糖监测临床应用指南 2015》新版发布！

2015-12-15

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：艾塞那肽、胰岛素或吡格列酮对T2DM患者的影响（CONFIDENCE系列研究）

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS2015：两项真实世界的糖尿病研究结果发布

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：纪立农教授公布SGLT-2抑制剂心血管终点（Empa-REG OT 研究）

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：滕卫平：1型糖尿病表观遗传学研究进展

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：ORBIT研究启示

2015-12-14

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2015：翁建平谈中国近20年糖尿病领域研究带给我们的启示

2015-12-11

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

MedSci参加中华医学会糖尿病学分会第十九次全国学术会议（CDS 2015）

2015-12-11

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

Lancet Oncol：连续深度镇静（CDS）可成为癌症晚期患者姑息治疗的选择

2015-11-23

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDSR：对孕妇进行生殖道感染的筛查和治疗是有必要的

2015-05-18

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDSR：孕期补充锌减少早产率

2015-05-18

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2014：基层——糖尿病防控**线

2014-11-13

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

项坤三院士获首届CDS科学贡献奖

2014-11-12

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2014：东西方胰岛素抵抗是否存在差异?

2014-11-12

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDSR：维生素C防治感冒—争论还在继续

2014-03-26

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS发布《基于胰高血糖素样肽-1降糖药物的临床应用共识》

2014-03-16

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDSR：β-内酰胺类加氨基糖苷类抗生素有害

2014-03-05

yangpeizhi (审核中...)

前往app查看评论内容

#CDS#

CDS 2013：中国糖尿病研究获奖名单

2013-12-08

科室
- - 订阅+
  - 更多科室
工具
服务